Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Lax-suppositories Glycerol |
| Active Ingredient: | Glycerol 2800mg |
| Dosage Form: | Suppository |
| New Zealand Sponsor: | AFT Pharmaceuticals Limited |
| Manufacturer: | Bliss GVS Pharma Limited, Palghar, India |
| Product: | Piperacillin/Tazobactam Kabi |
| Active Ingredients: | Piperacillin sodium 2.085g equivalent to piperacillin 2g Tazobactam sodium 0.2683g equivalent to tazobactam 0.25g |
| Dosage Form: | Powder for injection |
| New Zealand Sponsor: | Fresenius Kabi New Zealand Limited |
| Manufacturer: | Labesfal Laboratories Almiro SA, Santiago de Besteiros, Portugal |
| Product: | Piperacillin/Tazobactam Kabi |
| Active Ingredients: | Piperacillin sodium 4.17g equivalent to piperacillin 4g Tazobactam sodium 0.5366g equivalent to tazobactam 0.5g |
| Dosage Form: | Powder for injection |
| New Zealand Sponsor: | Fresenius Kabi New Zealand Limited |
| Manufacturer: | Labesfal Laboratories Almiro SA, Santiago de Besteiros, Portugal |
Dated this 5th day of April 2022.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).